Vertex inhibitors of Aurora-2, glycogen synthase kinase-3 and Src kinase

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.3, 2004-03, pp. : 439-443

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2790-2798

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of glycogen synthase kinase-3: future therapy for unmet medical needs?

By Dorronsoro Isabel Castro Ana Martinez Ana

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 10, 2002-10 ,pp. : 1527-1536

Informa Healthcare

Access to resources Recommend Favorite

Design of Glycogen Synthase Kinase-3 Inhibitors: An Overview on Recent Advancements

Current Pharmaceutical Design, Vol. 19, Iss. 26, 2013-08 ,pp. : 4755-4775

Bentham Science Publishers

Access to resources Recommend Favorite

Challenges and opportunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment

By Eldar-Finkelman Hagit Ilouz Ronit

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1511-1519

Informa Healthcare

Access to resources Recommend Favorite

The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes

By Eldar-Finkelman Hagit Kaidanovich Oksana

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 5, 2002-10 ,pp. : 555-561

Informa Healthcare

Access to resources Recommend Favorite